Vanderbilt University Medical Center: ASCO Press Program Highlights COVID-19 Outcomes in Lung Cancer Patients
May 27, 2020
May 27, 2020
NASHVILLE, Tennessee, May 27 -- Vanderbilt University Medical Center issued the following news:
People with thoracic cancers sickened by COVID-19 were especially vulnerable to deaths with a 35% mortality rate, according to early results from TERAVOLT, a global consortium that tracks outcomes among this vulnerable patient population.
Much of the early data was accumulated when the pandemic was first sweeping through Italy and other European nations. Updated data from the . . .
People with thoracic cancers sickened by COVID-19 were especially vulnerable to deaths with a 35% mortality rate, according to early results from TERAVOLT, a global consortium that tracks outcomes among this vulnerable patient population.
Much of the early data was accumulated when the pandemic was first sweeping through Italy and other European nations. Updated data from the . . .